|
 |
Brimonidine tartrateThis page contains recent news articles, when available, and an overview of Brimonidine tartrate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Brimonidine tartrate (when available) Brimonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow. For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Mechanism Of Action: Brimonidine is an alpha adrenergic receptor agonist. It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow. News Articles on Brimonidine Allergan wins brimonidine patent infringement case - Nov 4, 2009 ...purported generic versions of the company's formulations of brimonidine tartrate 0.1% and 0.15% (Alphagan P) for ocular hypertension and glaucoma. ... ModernMedicine Allergan wins patent infringement suit over generic versions of brimonidine - Oct 30, 2009 Allergan filed the suit claiming the defendants infringed on the patent for Alphagan (brimonidine tartrate ophthalmic solution 0.1% and 0.15%) when seeking ... OSN SuperSite Allergan Reports Third Quarter 2009 Operating Results - Oct 29, 2009 ...proposed generic versions of Allergan`s ALPHAGAN P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% products infringe Allergan`s patents. ... Reuters Allergan wins brimonidine patent infringement case against Exela PharmSci & Apotex - Oct 27, 2009 ...the 'Defendants') for seeking to market purported generic versions of Allergan's drugs Alphagan P (brimonidine tartrate ophthalmic solution) 0.1% and ... pharmabiz.com … for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic - Dec 21, 2006 COMBIGAN(TM) includes two agents known to reduce IOP - ALPHAGAN(R) (brimonidine tartrate ophthalmic solution 0.2%) and timolol ophthalmic solution 0.5%, ... Genetic Engineering News - Genetic Engineering News (press release) Study: Brimonidine tartrate shows short-term efficacy for reducing... - Jun 10, 2008 Brimonidine tartrate can successfully reduce halo size and pupil size in patients with night-vision symptoms after LASIK, a small 24-hour study by ... OSN SuperSite … for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic ... - Oct 31, 2007 Allergan, Inc. (NYSE:AGN) today announced that the US Food and Drug Administration has approved COMBIGAN([TM]) (brimonidine tartrate/timolol maleate ... $4.95 - Business Wire - ECNext Article: Allergan said the FDA approved Combigan (brimonidine... - Dec 1, 2007 Allergan said the FDA approved Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%.(Pipeline) ... find Medical Marketing & Media ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Loislaw Federal District Court Opinions - ALLERGAN, INC. v. ALCON INC... - Dec 8, 2005 B. Brimonidine Tartrate, Its Uses, and Allergan's Market Exclusivity The ... Alpha-2-adrenergic agonists, including brimonidine tartrate, are used to treat ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Changes in visual function after intraocular pressure reduction using... - Aug 1, 2008 Not all patients were receiving antiglaucoma treatment when included in the study, and they randomly received timolol maleate 0.5%, brimonidine tartrate ... Nature.com Loislaw Federal District Court Opinions - ALLERGAN v. ALCON (Del. … - Dec 4, 2005 B. Brimonidine Tartrate, Its Uses, and Allergan's Market Exclusivity The ... Alpha-2-adrenergic agonists, including brimonidine tartrate, are used to treat ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Allergan reports 23% rise in first-quarter total product net sales - May 8, 2008 Alphagan P (brimonidine tartrate 0.15%), Alphagan (brimonidine tartrate) and Combigan (0.2% brimonidine tartrate, 0.5% timolol maleate) sales totaled $99.5 ... OSN SuperSite Allergan receives FDA nod for glaucoma drug Combigan - Nov 3, 2007 Allergan, Inc. announced that the US Food and Drug Administration has approved Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2 per ... pharmabiz.com Alcon and Allergan Reach Agreement on Brimonidine 0.15% Patent … - Mar 9, 2006 The first lawsuit was filed by Allergan in the US District Court for the District of Delaware claiming that Alcon's proposed brimonidine tartrate 0.15% ... Free with registration - Business Wire - AccessMyLibrary.com Allergan reports 20.1% rise in second-quarter product sales - Aug 1, 2008 Alphagan P (brimonidine tartrate 0.15%), Alphagan (brimonidine tartrate) and Combigan (0.2% brimonidine tartrate, 0.5% timolol maleate) sales totaled ... OSN SuperSite FDA Approvals: Aceon, 0.1% Alphagan P, Namenda Oral Solution - Aug 25, 2005 19, the FDA approved a 0.1% formulation of brimonidine tartrate ophthalmic solution (Alphagan P, made by Allergan, Inc.) for lowering intraocular pressure ... Medscape Watch for toxic brimonidine exposure in children.(Clinical Rounds)(Bri... - Sep 1, 2006 SAN FRANCISCO -- Toxic exposures to brimonidine tartrate affected 43-55 patients per year between 2000 and 2005, and more than half of them were children 5 ... Free with registration - Family Practice News - AccessMyLibrary.com New formulation of Allergan's Alphagan P receives US FDA approval. - Aug 19, 2005 The new product is an optimised formulation of Alphagan (brimonidine tartrate ophthalmic solution) 0.2% and was developed to further minimise drug exposure ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Allergan gains FDA appro for Combigan. - Nov 12, 2007 The US Food and Drug Administration has approved Allergan's Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, ... $4.95 - Pharma Marketletter - ECNext Watch for toxic brimonidine exposure in children.(Clinical Rounds)(Bri... - Sep 1, 2006 SAN FRANCISCO -- Toxic exposures to brimonidine tartrate affected 43-55 patients per year between 2000 and 20... Pay-Per-View - Family Practice News - HighBeam Research Press Release: Lotus Pharmaceuticals, Inc. Announces First Quarter … - May 21, 2008 We focused our sales efforts on our top selling products, Brimonidine Tartrate Eyes Drops and VALSARTAN Capsules, and continued to distribute higher-margin, ... Pay-Per-View - PR Newswire - HighBeam Research Allergan Reports First Quarter Operating Results and Increases Full... - Apr 27, 2005 ...--The FDA issued an approvable letter for Alphagan(R) Z (brimonidine tartrate ophthalmic solution), for the lowering of intraocular pressure in patients ... $4.95 - Business Wire - ECNext Most brimonidine poisonings occur in child aged 5 or less.(Clinical … - Sep 1, 2006 Rounds) ... find Pediatric News articles. SAN FRANCISCO -- Toxic exposures to brimonidine tartrate affected 43-55 patients per year between 2000 and 20... Pay-Per-View - Pediatric News - HighBeam Research Northwest, Merck, HJ Heinz - Aug 20, 2005 The new formulation is a 0.1% brimonidine tartrate ophthalmic solution as opposed to the original 0.2% formulation. A shareholder derivative complaint has ... MarketWatch Cost of glaucoma medications may impact treatment - Dec 30, 2007 The generic selective a2-agonist brimonidine tartrate 0.2% costs approximately $352.89 and $529.34 per year for the respective two and three drops daily per ... The Hindu Adrenergic agonists for glaucoma - May 23, 2008 A commonly used adrenergic agonist (brimonidine tartrate) eyedrop has a purple bottle cap. If you need to use more than one type of eyedrop, you may need to ... WebMD Comparison study: brimonidine fares well as add-on therapy: addition... - Jan 15, 2008 New Orleans -- The addition of brimonidine tartrate 0.15 % (Alphagan P, Allergan) to a prostaglandin analog resulted in significantly greater reductions in ... Free with registration - Ophthalmology Times - AccessMyLibrary.com Allergan Reports Fourth Quarter Operating Results.(Financial report) - Jan 31, 2007 On December 21, 2006, Allergan announced that the FDA issued an approvable letter for COMBIGAN[TM] (brimonidine tartrate/timolol maleate ophthalmic ... Free with registration - Business Wire - AccessMyLibrary.com Akorn wins FDA approval for glaucoma treatment - Mar 20, 2006 The approval covers a solution of brimonidine tartrate, the active ingredient in Allergan Inc.'s Alphagan P. The solution works by decreasing the pressure ... Crain's Chicago Business Costs Rising to Make Intraocular Pressure Fall - Dec 28, 2007 Generic brimonidine tartrate 0.2% was less expensive, but again the 15.0 mL bottle was actually more expensive than the 10.0 mL bottle at $383.82 and ... MedPage Today Allergan Receives Positive Opinions for COMBIGAN(TM) From 21 … - Sep 28, 2005 Allergan's ALPHAGAN(R)/timolol combination product for glaucoma (brimonidine tartrate/timolol ophthalmic solution), from all twenty-one Concerned Member ... RedOrbit Genesis and Beijing Pharmaceuticals Partner Announce Four New Drugs … - May 11, 2006 Exclusive new drug curing open-angle glaucoma, alpha-2 Receptor Excitant-brimonidine tartrate material and eye drops (Muxin) was approved by the State SFDA ... primezone.com Lotus Pharmaceuticals Announces Third Quarter 2008 Results - Nov 18, 2008 This increase was attributable to strong sales for the Company's Brimonidine Tartrate Eye Drops, used in the treatment of glaucoma, and strong sales of a ... Genetic Engineering News - Genetic Engineering News (press release) SLT comparable with medical therapy for open-angle glaucoma: added … - Jan 15, 2007 In the third step, brimonidine tartrate (Alphagan, Allergan) was added or substituted, and in the fourth step, dorzolamide (Trusopt, Merck), ... Free with registration - Ophthalmology Times - AccessMyLibrary.com OCULAR SURGERY NEWS US EDITION September 15, 2005 - Sep 15, 2005 US regulators have granted marketing approval to Allergan's Alphagan P (brimonidine tartrate) 0.1% for the lowering of IOP in patients with open-angle ... OSN SuperSite TheSUBWAY.coms Early Stock Market Alerts for Wednesday, July 25, … - Jul 25, 2007 Brimonidine tartrate eye drops for the treatment of glaucoma and ocular hypertension, with annual sales estimated at $4 million. ... Free with registration - M2 Presswire - AccessMyLibrary.com Panel weighs pros and cons of fixed combination therapy for glaucoma - Oct 17, 2005 The panel noted that the fixed combination product containing brimonidine tartrate 0.2% and timolol 0.5% (Combigan, Allergan) is a rationale choice since it ... Ophthalmology Times Lotus Pharmaceuticals Announces Second Quarter 2008 Results - Aug 18, 2008 This increase was because of increased sales of third- party pharmaceuticals and increased sales of the Company's Brimonidine Tartrate Eyes Drops (sold ... Genetic Engineering News - Genetic Engineering News (press release) Article: Allergan patents self tanning method. - Household & Personal... - Aug 1, 2006 Ophthalmology Times; April 15, 2006 ; 692 words ... ... s proposed brimonidine tartrate 0.15% solution made with polyquaternium-1 (Polyquad) preservative ... Pay-Per-View - Household & Personal Products Industry - HighBeam Research Fixed combination glaucoma medications await US approvals - Nov 1, 2005 Combigan (timolol maleate 0.5%, brimonidine tartrate 0.2%, Allergan) and an as-yet unbranded combination of bimatoprost and timolol, also from Allergan. ... OSN SuperSite Meticulous attention to detail can help prevent or manage surgical … - Sep 1, 2007 Alphagan (brimonidine tartrate, Allergan) can help reduce some pupils with different lighting conditions and will not constrict, he said. ... OSN SuperSite Prasco Laboratories Pictures from October 28, 2008 | HighBeam … - Oct 28, 2008 R]) (bimatoprost ophthalmic solution) 0.03% and ALPHAGAN ... P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15 ... ... Pay-Per-View - AP Images - HighBeam Research Allergan Reports Second Quarter Operating Results and Increases Full ... - Jun 24, 2005 The FDA issued an approvable letter for Alphagan(R) Z (brimonidine tartrate ophthalmic solution) for the lowering of intraocular pressure in patients with ... businesswire.com Ophthalmologists face reimbursement cuts despite some gains in eye … - Dec 1, 2007 Combigan consists of two already-approved therapies, brimonidine tartrate 0.2% and timolol maleate 0.5%. It is expected to enter the US market by the end of ... OSN SuperSite AAO 2007 New Orleans exhibitor's guide.(Special Section: AAO Exhibitor... - Nov 1, 2007 Allergan's commitment to eye care includes bimatoprost ophthalmic solution 0.03% (Lumigan); brimonidine tartrate ophthalmic solution 0.1% and 0.15% ... Free with registration - Ophthalmology Times - AccessMyLibrary.com Piggyback IOL may resolve poor postop acuity, halos - Oct 1, 2005 After ruling out IOL exchange and Alphagan (brimonidine tartrate, Allergan) and pilocarpine drops as treatment options, Dr. Ernest drew on his experience ... OSN SuperSite Article: The effect of natural sunlight on ciprofloxacin ophthalmic... - Oct 1, 2005 R]) (bimatoprost ophthalmic solution) 0.03% and ALPHAGAN ... P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15 ... ... Pay-Per-View - Journal of the Mississippi Academy of... - HighBeam Research Article: Local Focus.(Business) - Daily Herald (Arlington Heights,... - Jul 28, 2007 R]) (bimatoprost ophthalmic solution) 0.03% and ALPHAGAN ... P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15 ... ... Pay-Per-View - Daily Herald - HighBeam Research Article: PediaMed has entered into a US co-promotion agreement for … - Apr 1, 2005 R]) (bimatoprost ophthalmic solution) 0.03% and ALPHAGAN ... P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15 ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Combigen gets FDA approvable letter. - Jan 8, 2007 California, USA-based pharmaceutical firm Allergan says that Combigan (brimonidine tartrate/timolol maleate opthalmic solution) 0.2%/0.5%, under development ... $9.94 - Pharma Marketletter - Alacra Store Allergan Reports Second Quarter Operating Results and Increases Full ... - Jul 27, 2005 ...--The FDA issued an approvable letter for Alphagan(R) Z (brimonidine tartrate ophthalmic solution) for the lowering of intraocular pressure in patients with ... $4.95 - Business Wire - ECNext Last-minute 2006 US FDA decisions end with mostly "approvable" letters - Jan 4, 2007 California, USA-based pharmaceutical firm Allergan's drug Combigan (brimonidine tartrate/timolol maleate opthalmic solution) 0.2%/0.5%, under development as ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Combigan. - Dec 10, 2007 Allergan Inc., Irvine, Calif., (714) 246-4500, has FDA approval for Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%. ... $9.94 - Drug Topics - Alacra Store Press Release: International Survey Shows People Over Forty Ignore … - Oct 2, 2007 R)/timolol combination product for glaucoma (brimonidine tartrate/timolol ophthalmic ... in patients with chronic open-angle glaucoma or ocular hypertension ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Allergan Receives Positive Opinions for COMBIGAN(TM) … - Sep 29, 2005 Allergan's ALPHAGAN(R)/timolol combination product for glaucoma (brimonidine tartrate/timolol ophthalmic solution), from all twenty-one Concerned Member ... Pay-Per-View - PR Newswire Europe - HighBeam Research FDA clears new formulation of Allergan's Alphagan P.(Food and Drug … - Aug 29, 2005 ...the Food and Drug Administration to market a new formulation of its ocular hypertension drug Alphagan P (brimonidine tartrate ophthalmic solution) 0.1%. ... $4.95 - Pharma Marketletter - ECNext Factiva Search - Jan 3, 2007 California, USA-based pharmaceutical firm Allergan says that Combigan (brimonidine tartrate/timolol maleate opthalmic ... Copyright 2007. ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones FDA APPROVES LESS POTENT FORMULA OF ALPHAGAN GLAUCOMA … - Aug 23, 2005 The new formulation of Alphagan contains 0.1 percent of the active ingredient, brimonidine tartrate ophthalmic solution, while the original Alphagan ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones Florida Administrative Code - 64B13-18.002 Formulary of Topical... - Jul 5, 2005 Brimonidine tartrate — 0.15%, 0.2%; and 2. Apraclonidine HCI — 0.5%. (e) Carbonic Anhydrase Inhibitors (CAI's) 1. Brinzolamide — 1.0%; and 2. ... Pay-Per-View - Florida Administrative Code - Loislaw OVER THE COUNTER: New prescription product - Combigan.(Brief … - Jun 4, 2005 Eye drops containing brimonidine tartrate 2mg and timolol 5mg per 5ml Usual dose: one drop into the affected eye twice daily Cautions: should not be used in ... $4.95 - Chemist & Druggist - ECNext Article: Pacific Communications has been named agency of record for … - Jan 1, 2007 Allergan said the FDA approved Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, for the reduction of elevated intraocular ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Combigan for glaucoma.(Brief Article) - Jun 21, 2005 Allergan has launched Combigan eye drops (brimonidine tartrate 2mg, timolol 5mg) for reducing intraocular pressure in patients with chronic open-angle ... $4.95 - Community Pharmacy - ECNext OVER THE COUNTER: New prescription product - Combigan. - Jun 4, 2005 Eye drops containing brimonidine tartrate 2mg and timolol 5mg per 5ml For reducing pressure in the eye in patients with chronic open-angle glaucoma or ... $9.94 - Chemist & Druggist - Alacra Store Combigan for glaucoma. - Jun 21, 2005 Allergan has launched Combigan eye drops (brimonidine tartrate 2mg, timolol 5mg) for reducing intraocular pressure in patients with chronic open-angle ... $9.94 - Community Pharmacy - Alacra Store Tartrato de brimonidina: su eficacia para reducir halos después de... - Sep 10, 2008 Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients; the Brimonidine Study Group. Am J Ophthalmol 1999; ... Intramed.net - Intramed.net (Suscripción) Loislaw Federal District Court Opinions - McELHINNEY v. ASTRUE (Ariz.... - Aug 12, 2008 Flunisolide nasal spray, Omeprazole "for stomach (should help asthma)", Alprazolam to help with sleep and anxiety, Brimonidine Tartrate and Travoprost ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Brand Names/Synonyms: Brimonidine tartrate is also known by the following brand names and/or synonymsAlphagan; Alphagan P; Brimonidine; Brimonidine Tartrate; Bromoxidine; CHEMBANK1623 Drug Category: Brimonidine tartrate is categorized under the following by the FDA: Antihypertensive Agents; EENT Drugs; ATC:S01EA05 Dosage Forms: 0.2% solution Absorption: Minimal systemic absorption occurs after ocular insertion. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
